$0.6982
0.0432[6.60%]
At close: May 16
$0.6982
0[0.00%]
PreMarket: 5:56PM EDT
Aligos Therapeutics
(NASDAQ:ALGS)Aligos Therapeutics Stock (NASDAQ:ALGS), Earnings Estimates, EPS, and Revenue
Aligos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS
$-0.220
Quarterly Revenue
$986K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$13.8M
Analyze the earnings history of Aligos Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALGS | Aligos Therapeutics | -$0.43 | — | — | — | $2.59M | — | — | — | 08/01/2024 | Get Alert |
| ALGS | Aligos Therapeutics | -$0.53 | -$0.19 | -$0.22 | -15.79% | $2.72M | — | $986.00K | — | 05/07/2024 | Get Alert |
| ALGS | Aligos Therapeutics | -$0.51 | -$0.27 | -$0.22 | 18.52% | $3.54M | $1.60M | $2.01M | 25.56% | 03/12/2024 | Get Alert |
| ALGS | Aligos Therapeutics | -$0.44 | -$0.47 | -$0.41 | 12.77% | $4.11M | $2.50M | $2.15M | -13.84% | 11/02/2023 | Get Alert |
| ALGS | Aligos Therapeutics | -$0.47 | -$0.49 | -$0.43 | 12.24% | $3.69M | — | $2.59M | — | 08/03/2023 | Get Alert |
| ALGS | Aligos Therapeutics | -$0.84 | -$0.48 | -$0.53 | -10.42% | $2.57M | — | $2.72M | — | 05/04/2023 | Get Alert |
| ALGS | Aligos Therapeutics | -$0.89 | -$0.47 | -$0.51 | -8.51% | $367.00K | $1.72M | $3.54M | 105.64% | 03/09/2023 | Get Alert |
| ALGS | Aligos Therapeutics | -$0.78 | -$0.58 | -$0.44 | 24.14% | $1.54M | — | $4.11M | — | 11/02/2022 | Get Alert |
| ALGS | Aligos Therapeutics | -$0.79 | -$0.67 | -$0.47 | 29.85% | $1.54M | — | $3.69M | — | 08/04/2022 | Get Alert |
| ALGS | Aligos Therapeutics | -$0.74 | -$0.73 | -$0.84 | -15.07% | $910.00K | — | $2.57M | — | 05/04/2022 | Get Alert |
| ALGS | Aligos Therapeutics | -$1.09 | -$0.83 | -$0.89 | -7.23% | $0.00 | — | $367.00K | — | 03/10/2022 | Get Alert |
| ALGS | Aligos Therapeutics | -$11.00 | -$0.81 | -$0.78 | 3.70% | $0.00 | — | $1.54M | — | 11/04/2021 | Get Alert |
| ALGS | Aligos Therapeutics | — | -$0.81 | -$0.79 | 2.47% | — | — | $1.54M | — | 08/05/2021 | Get Alert |
| ALGS | Aligos Therapeutics | — | -$0.90 | -$0.74 | 17.78% | — | — | $910.00K | — | 05/10/2021 | Get Alert |
| ALGS | Aligos Therapeutics | -$7.27 | — | -$1.09 | — | — | — | $0.00 | — | 03/23/2021 | Get Alert |
| ALGS | Aligos Therapeutics | — | — | -$11.00 | — | — | — | $0.00 | — | 11/25/2020 | Get Alert |
FAQ
When is Aligos Therapeutics (NASDAQ:ALGS) reporting earnings?
Aligos Therapeutics (ALGS) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
What were the latest earnings per share (EPS) for Aligos Therapeutics (NASDAQ:ALGS)?
The Actual EPS was $-0.22, which missed the estimate of $-0.19.
What were Aligos Therapeutics’s (NASDAQ:ALGS) revenues?
The Actual Revenue was $986K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.